Kyle is a Senior Principal Engineer in the Cell and Gene Therapy R&D group based in Lake Zurich, Illinois, USA, with expertise in advanced engineering systems and cross-functional product development. He holds both a Master of Science and a Bachelor of Science in Biomedical Engineering from the University of Michigan. With over 10 years at Fresenius Kabi, Kyle has played key roles in the development of the Lovo and Cue Cell Processing systems. As a contributor to the EASYGEN Consortium, he supports the advancement of next-generation CAR-T manufacturing technologies.